|
Age (median ± IQR)
|
67 ± 26
|
71 ± 43
|
0.999
|
|
Elderly patient
|
17 (55)
|
7 (58)
|
0.836
|
|
Immunocompromised
|
22 (71)
|
7 (58)
|
0.482
|
|
Neurological finding
|
9 (29)
|
2 (17)
|
0.698
|
|
GCSb at presentation (median ± IQR)
|
13 ± 11
|
13 ± 8
|
0.453
|
|
Classic Triadc
|
14 (45)
|
7 (58)
|
0.438
|
|
WBC > 999 cells/mL
|
10 (33)
|
5 (42)
|
0.282
|
|
Protein level g/L (median ± IQR)
|
2.08 ±1.3
|
2.1 ± 4.4
|
0.685
|
|
CSFd/blood glucose ratio (median ± IQR)
|
0.27 ± 0.24
|
0.18 ± 0.21
|
0.448
|
|
Hyponatremia
|
13 (42)
|
6 (50)
|
0.633
|
|
Seizures
|
2 (7)
|
2 (17)
|
0.308
|
|
Empirical Ampicilllin + gentamicin therapy
|
8 (26)
|
3 (25)
|
0.957
|
|
Definitive Ampicillin + gentamicin therapy
|
10 (32)
|
8 (67)
|
0.040
|
|
Dexamethasone concomitant to antibiotic
|
17 (55)
|
4 (33)
|
0.206
|
|
Phenytoin
|
8 (26)
|
3 (25)
|
0.999
|
